We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
-15.8%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$537M
AUM Growth
-$133M
(-20%)
Cap. Flow
-$47.6M
Cap. Flow
% of AUM
-8.86%
Top 10 Holdings %
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$10.5M |
| 2 |
Truist Financial
TFC
|
+$8.46M |
| 3 |
Qualcomm
QCOM
|
+$8.04M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.59M |
| 5 |
EOG Resources
EOG
|
+$4.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.6M |
| 2 |
Occidental Petroleum
OXY
|
+$8.04M |
| 3 |
ExxonMobil
XOM
|
+$7.72M |
| 4 |
Verizon
VZ
|
+$4.51M |
| 5 |
Dick's Sporting Goods
DKS
|
+$4.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.92% |
| 2 | Healthcare | 13.25% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 11.7% |
| 5 | Financials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
676
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $118K | 0.02% |
+23,800
| New | +$132K |
|
677
Extreme Networks
EXTR
$2.88B
| $117K | 0.02% |
+13,172
| New | +$134K |
|
678
Adecoagro
AGRO
$1.68B
| $115K | 0.02% |
+13,589
| New | +$146K |
|
679
Arlo Technologies
ARLO
$1.46B
| $115K | 0.02% |
18,289
+3,399
| +23% | +$24.9K |
|
680
ADMA Biologics
ADMA
$2.01B
| $109K | 0.02% |
+55,300
| New | +$109K |
|
681
Riot Platforms
RIOT
$7.67B
| $108K | 0.02% |
+25,743
| New | +$239K |
|
682
Akebia Therapeutics
AKBA
$257M
| $107K | 0.02% |
+304,100
| New | +$128K |
|
683
Cogent Biosciences
COGT
$5.71B
| $105K | 0.02% |
+11,615
| New | +$79.3K |
|
684
indie Semiconductor
INDI
$700M
| $103K | 0.02% |
+18,116
| New | +$125K |
|
|
EMBJ
685
Embraer S.A. ADS
EMBJ
$13.3B
| $100K | 0.02% |
+11,400
| New | +$122K |
|
686
Harmonic Inc
HLIT
$1.25B
| $98K | 0.02% |
+11,343
| New | +$102K |
|
687
Hudbay
HBM
$11.3B
| $97K | 0.02% |
+23,800
| New | +$142K |
|
688
Kodiak Sciences
KOD
$2.06B
| $95K | 0.02% |
12,439
-11,200
| -47% | -$78.7K |
|
|
CBD
689
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $95K | 0.02% |
30,800
+15,600
| +103% | +$66.2K |
|
|
DADA
690
DELISTED
Dada Nexus
DADA
| $93K | 0.02% |
11,503
+703
| +7% | +$5.4K |
|
691
TG Therapeutics
TGTX
$8.54B
| $92K | 0.02% |
+21,700
| New | +$135K |
|
692
ACV Auctions
ACVA
$1.77B
| $88K | 0.02% |
13,500
-37,800
| -74% | -$389K |
|
|
RAD
693
DELISTED
Rite Aid Corporation
RAD
| $87K | 0.02% |
+12,947
| New | +$85.7K |
|
694
Fossil Group
FOSL
$312M
| $86K | 0.02% |
+16,619
| New | +$135K |
|
695
Opko Health
OPK
$1.22B
| $85K | 0.02% |
+33,700
| New | +$98.3K |
|
696
Kodak
KODK
$917M
| $82K | 0.02% |
+17,655
| New | +$92.1K |
|
697
Annaly Capital Management
NLY
$16.1B
| $81K | 0.02% |
3,425
-12,450
| -78% | -$323K |
|
|
APPH
698
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $81K | 0.02% |
+23,100
| New | +$82.8K |
|
|
CHS
699
DELISTED
Chicos FAS, Inc.
CHS
| $80K | 0.01% |
+16,000
| New | +$80.9K |
|
700
DigitalBridge
DBRG
$2.98B
| $79K | 0.01% |
+4,050
| New | +$98.9K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.
- Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
- Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
- Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
- Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
- Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
- Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
- Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.
Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.